Is propanol useful

Propranolol is genuinely useful after a heart attack, and the evidence there uses hard outcomes, not lab values.

The strongest data is the Beta-Blocker Heart Attack Trial: propranolol cut total deaths from 9.8% to 7.2% over about two years, a 26% relative drop, with sudden death and nonfatal reinfarction also down [1]. That is roughly 2 to 3 fewer deaths per 100 people treated. The benefit was similar across risk and age groups [1]. It also blunted the morning surge in sudden death seen on placebo [2], and in patients with persistent ST depression after a first heart attack the mortality gap was wider, 7.6% versus 13.6% [4].

The costs are real. More people stopped propranolol for low blood pressure, 22 versus 6 [1]. New heart failure was equal in both groups at 6.7% [1]. One comparison found propranolol carried slightly higher two-year mortality than metoprolol or atenolol [3], so the class is not interchangeable.

These trials are old and largely predate modern reperfusion and statin care, so the absolute benefit today is probably smaller than these numbers. The retrieval did not surface a modern post-heart-attack trial to settle that.

My call: for someone who has had a heart attack, propranolol is worth taking, with the caveat that other beta-blockers may be preferred. Confidence: moderate, because the benefit is proven on hard outcomes but the trials are decades old.